-205 in EBV-negative lymphoma compared to thymus and the induction of the miRNA in EBV-positive ones. We next analysed by qRT-PCR the relative expression levels of deregulated miRNAs in the NK/T-cell lines SNT6 and SNK16, one further case of nasal NK/T-cell lymphoma where frozen tissue was available and three additional cases of nasal NK/T-cell lymphoma where only paraffin-embedded material was available. These were either compared with primary thymus tissue or CD56+ cells isolated from healthy donors. It is assumed that CD56+/CD3+ cells are the precursor cells for EBV-positive NK/ T-cell lymphoma. When compared to primary thymus tissue, the tested miRNAs miR-142-3p, -145, -181b, -200c, -205 and 424 all were down-regulated in the tumor tissues and the cell lines tested, with the exception of miR-181b and miR-424 that essentially showed no SGI1776 chemical information change in the primary, frozen tissue of the NK/T-cell lymphoma. This is shown in supplementary miRNA 
relative expression Thymus EBV0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,01 0,02 0,03 EBV+ 0,09 1,18 0,10 0,07 0,28 0,07 0,21 0,21 0,22 1,03 Identification of the Pro-inflammatory Cytokine IL1A as a Target of the Deregulated miR-142-3p We then went on to identify potential targets for the deregulated cellular miRNAs. A previous study had determined the mRNA expression profile of EBV-infected nasal NK/T-cell lymphoma lines and found, among others, the IL1A, BCL6, CD44 and cFOS genes to be induced and the interleukin 1 receptor 1 gene to be repressed compared to normal lymphocytes. By applying a combination of various prediction algorithms, we identified the 39-UTR of c-FOS as a potential target for miR-181a and miR-181b, CD44 as a potential target of miR-20a and miR-106a, and the IL1R1 as a target of miR-205 and -125a. When we tested the 39-UTRs of these genes in a luciferase reporter assay with the respective miRNAs, we did not observe an effect of any of these miRNAs on the reporter constructs. Expression hsa-miR-200a hsa-miR-200b hsa-miR-203 hsa-miR-204 hsa-miR-205 hsa-miR-429 hsa-miR-449a+449b hsa-miR-141 hsa-miR-199b-5p hsa-miR-200c 0,26 2,17 0,11 0,12 1,49 0,15 0,00 0,36 0,26 0,88 doi:10.1371/journal.pone.0042193.t001 MiRNA Profile of EBV-Positive NK/T-Cell Lymphoma name sequence genomic location reads in libraries Thymus EBVEBV+ 4 4 4 1 2 10 PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22203538 3 2 3 2 1 hsa-miR-874-5p hsa-miR-1248-3p hsa-miR-153-2-5p hsa-miR-98-3p hsa-miR-382-3p hsa-miR-511-3p hsa-miR-1277-5p hsa-miR-1185-3p has-miR-107-5p hsa-miR-let-7c-3p CGGCCCCACGCACCAGGGT TGCTAGCAGAGTACACACAAG GTCATTTTTGTGATGTTGCAGC CTATACAACTTACTACTTTC AATCATTCACGGACAACACTT AATGTGTAGCAAAAGACAG TATATATATATATGTACGTAT ATATACAGGGGGAGACTCTTAT AGCTTCTTTACAGTGTTGCCTTGT CTGTACAACCTTCTAGCTTTCC 5q31.2 3q27.3 7q36.3 Xp11.22 14q32.31 10p12.33 11q24 14q32.31 10q23.31 21q21.2 1 doi:10.1371/journal.pone.0042193.t002 of the cloned miRNAs from the vector pSG5 is shown in supporting sequence of potential binding site for miR-205 on the BCL6 39UTR was then changed by site-directed mutagenesis and assayed again with miR-205. The mutated reporter lost its responsiveness demonstrating that the BCL6- 39UTR is a target of this miRNA. To show that miR205 indeed reduces the protein level of BCL6, the EBV-negative SUP-T1 T-cell line was transfected with miR-205 expression plasmid and the level of BCL6 protein was determined by Western blot. The densitometric analysis of the BCL6 signal indicated a reduction of BCL6 protein by 30%. A representative blot is shown in Discussion To the best of ou
